Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 7,418 | 3,573 | 9,538 | 12,743 | 6,786 |
| Gross Profit | 7,418 | 3,573 | 9,538 | 12,743 | 6,786 |
| Operating Expenses | 70,772 | 58,604 | 165,974 | 134,270 | 139,702 |
| Operating Income | -63,354 | -55,031 | -156,436 | -121,527 | -132,916 |
| Other Income | 2,407 | 4,153 | 4,487 | 4,214 | 4,386 |
| Pre-tax Income | -60,947 | -50,878 | -151,949 | -117,313 | -128,530 |
| Income Tax | -1,167 | N/A | -765 | -24,282 | N/A |
| Net Income Continuous | -59,780 | -50,878 | -151,184 | -93,031 | -128,530 |
| Net Income | $-59,780 | $-50,878 | $-151,184 | $-93,031 | $-128,530 |
| EPS Basic Total Ops | -2.02 | -3.51 | -14.48 | -10.86 | -18.99 |
| EPS Basic Continuous Ops | -2.02 | -3.51 | -14.48 | -10.86 | -18.99 |
| EPS Diluted Total Ops | -2.02 | -3.51 | -14.48 | -10.86 | -18.99 |
| EPS Diluted Continuous Ops | -2.02 | -3.51 | -14.48 | -10.86 | -18.99 |
| EPS Diluted Before Non-Recurring Items | -1.80 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-42,154 | $-51,313 | $-62,707 | $-116,507 | $-127,898 |